wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53275543-8882B5D3-5CAD-4C69-A47A-3EA80F5CACD9
Q53275543-8882B5D3-5CAD-4C69-A47A-3EA80F5CACD9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53275543-8882B5D3-5CAD-4C69-A47A-3EA80F5CACD9
MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2- Metastatic Breast Cancer.
P2860
Q53275543-8882B5D3-5CAD-4C69-A47A-3EA80F5CACD9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53275543-8882B5D3-5CAD-4C69-A47A-3EA80F5CACD9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d25d8daa8e03b0e57c5e6a4c57d866e3df42eb4f
P2860
The association of chemotherapy versus hormonal therapy and health outcomes among patients with hormone receptor-positive, HER2-negative metastatic breast cancer: experience from the patient perspective.